Dunlop A. Sinclair

Related Filers (1)

Other (3)

144
Friday, 12/1/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 11/17/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 11/9/2023
Filing for proposed sale of securities under Rule 144
Show More

Ownership (35)

4
Tuesday, 1/2/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/15/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/5/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/21/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/21/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/5/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/2/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/2/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/4/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/2/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/3/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/8/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/26/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/17/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/12/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/22/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/29/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/24/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/25/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/13/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/2/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/20/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/26/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/19/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/4/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/15/2020
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/7/2020
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/3/2020
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/20/2019
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/3/2019
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/9/2018
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/13/2017
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/8/2017
Apellis Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
Show More